CN211382841U

CN211382841U - Eczema medicine application

Info

Publication number: CN211382841U
Application number: CN201821137280.0U
Authority: CN
Inventors: 赵俊起
Original assignee: Individual
Current assignee: Individual
Priority date: 2018-07-18
Filing date: 2018-07-18
Publication date: 2020-09-01
Anticipated expiration: 2028-07-18

Abstract

The utility model discloses an eczema drug application, which comprises a protective layer, a drug coating layer and a surface application layer which are connected in a layered way, wherein the drug coating layer is in a mesh shape, one surface of the drug coating layer is a drug coating surface, and a drug application composition is adsorbed on the drug coating surface; the protective layer and the application layer are respectively arranged on two sides of the medicine coating layer, wherein the protective layer is attached to the outside of the medicine coating layer and is movably connected with the medicine coating layer, and the protective layer can be conveniently separated from the medicine coating layer; the dressing layer is coated on the other side of the medicine coating layer, connecting nodules for preventing the dressing layer from separating are arranged between the dressing layer and the medicine coating layer, and through holes are formed in the dressing layer. The utility model discloses mainly used eczema patient uses, is suitable for children's patient very much, and medicine and skin contact are abundant lasting, can effectively reduce the toxic and side effect that the sanguisorba arouses simultaneously again. The applying surface layer is provided with a through hole, and the through hole can be used for applying the liquid medicine for the second time and is convenient for ventilation.

Description

Eczema medicine application

Technical Field

The utility model belongs to the technical field of the skin is applied ointment or plaster for external use, especially, relate to a medicine applies subsides for treating eczema.

Background

Eczema, a common skin disease, is susceptible to secondary infection caused by skin itch, exudation, erosion and the like. Eczema is frequently generated in infants and treatment crowds, and some patients induce eczema due to bandage entanglement allergy after interventional examination; infants between 2 and 3 months are also susceptible to eczema. The patients under treatment have eczema, and if the patients are not treated in time, the patients do not recover well in a short time, and the further treatment of the patients is influenced. The infant suffers from eczema, on one hand, the infant is dysphoria and crying, and the sleep of adults and children is affected; on the other hand, eczema is mostly seen on the head and face, and a child patient can involuntarily scratch and itch, and can cause septicemia, toxemia and the like due to secondary local and lymph node infection. For eczema, external treatment is usually adopted, and itching-relieving and detoxifying drugs are generally applied to affected parts. The existing external medicament is mostly pasty and oily, and is easy to wipe off after being coated, so that the external medicament is difficult to keep for a long time. If the affected part is bandaged, the ventilation of the affected part is affected, and the rehabilitation is not facilitated. Moreover, infantile eczema, which is called infantile eczema, is a common skin disease in infants, and is frequently seen in infants of 2-3 months, but the infants have low body resistance and poor drug resistance, and the existing external medicine for treating eczema is not suitable for continuous treatment and application of infants due to the common toxic and side effects in the medicine.

SUMMERY OF THE UTILITY MODEL

The to-be-solved technical problem of the utility model is to provide a medicine application plaster which is convenient to use, has small toxic and side effect and is particularly suitable for infant eczema patients.

In order to solve the technical problem, the utility model comprises a protective layer, a medicine coating layer and a surface coating layer which are connected in a layered way, wherein the medicine coating layer is in a mesh shape, one surface of the medicine coating layer is a medicine coating surface, and a medicine coating composition is adsorbed on the medicine coating surface; the protective layer and the application layer are respectively arranged on two sides of the medicine coating layer, wherein the protective layer is attached to the outside of the medicine coating layer and is movably connected with the medicine coating layer, and the protective layer can be conveniently separated from the medicine coating layer; the dressing layer is coated on the other side of the medicine coating layer, connecting nodules for preventing the dressing layer from separating are arranged between the dressing layer and the medicine coating layer, and through holes are formed in the dressing layer.

The medicine coating is a sponge body, the through hole is provided with a hole cover connected with the surface coating layer into a whole, the surface coating layer around the hole cover is provided with connecting nodes, and the connecting nodes are binding wires for connecting the surface coating layer and the medicine coating.

The protective layer, the medicine coating layer and the face coating layer are all in strip shapes, the eczema medicine coating is formed by compounding and overlapping three layers of strips, a plurality of through holes are formed in the face coating layer along the length direction of the face coating layer, and the medicine coating roll is stored so as to be cut for use according to requirements.

The utility model is formed by a protective layer, a drug coating layer and a surface layer, wherein the drug coating layer is in a mesh shape, and the bottom surface of the drug coating layer is provided with a drug coating composition. When in use, the protective layer is removed, and the medicine coated surface of the medicine coating layer is pasted on the eczema skin of a patient and is fixed, so that the use is convenient. The medicinal composition adsorbed inside and outside the meshes of the medicinal coating is in loose contact with the skin, not only can exert medicinal effect, but also can not be adhered outside the skin, can keep good air circulation at the periphery of the skin, and is favorable for treating eczema. Meanwhile, the patch does not influence the movement of a patient, and is particularly suitable for children. The applying surface layer is provided with a through hole, and the through hole can be used for applying the liquid medicine for the second time and is convenient for ventilation.

Drawings

The invention will be further described with reference to the following figures and examples:

FIG. 1 is a schematic view of the whole eczema patch of the present invention;

FIG. 2 is a schematic view of the eczema patch of the present invention partially opened;

fig. 3 is a schematic view of the eczema plaster.

Detailed Description

Referring to the attached drawing, the eczema drug application patch comprises a protective layer 1, a drug application layer 2 and a face application layer 3 which are connected in a layered mode. The medicine coating 2 is in a mesh shape and can be made of medicinal cotton yarn or medicinal sponge; one surface of the medicine coating layer 2 is a medicine coating surface 21, ointment of the medicine coating composition is evenly coated on the medicine coating surface, and the medicine coating composition is adsorbed on micropores of the medicine coating surface. The protective layer 1 and the application layer 3 are respectively arranged on two sides of the medicine coating layer 2, wherein the protective layer 1 is attached on the surface of the medicine coating surface 21, the protective layer 1 can be made of thin film plastics and is attached to the medicine coating surface 21, and the protective layer 1 can be conveniently connected with and separated from the medicine coating layer 2. The dressing layer 3 is covered on the other side of the medicine dressing layer 2, the dressing layer 3 can be made of disposable non-woven fabric, and a connecting node 5 for preventing the dressing layer 2 from separating is arranged between the dressing layer and the dressing layer. In order to facilitate ventilation and secondary medicine adding, a plurality of through holes 4 are arranged on the surface layer 3.

Referring to fig. 2, the eczema medicine application is characterized in that the medicine coating layer 2 is a medicinal sponge body, the through hole 4 on the coating layer 3 is provided with a hole cover 41 which is connected with the coating layer 3 into a whole, the periphery of the hole cover 41 is pressed with a toothed hole, and the hole cover 41 is torn off when in use. The face coating layer 3 around the hole cover 41 is provided with a connecting node 5, and the connecting node 5 is a fiber binding wire for connecting the face coating layer 3 and the medicine coating layer 2.

Referring to fig. 3, the protective layer 1, the medicine application layer 2 and the face application layer 3 of the eczema medicine application are all in strip shapes, the eczema medicine application is formed by compounding and overlapping three layers of strips, a plurality of through holes 4 are formed in the face application layer 3 along the length direction of the face application layer, and the medicine application is rolled and stored so as to be cut for use as required.

The medicine application composition of the eczema medicine application and the preparation method thereof are as follows:

the medicinal application composition is a traditional Chinese medicine micro powder egg yolk ointment which is prepared by blending traditional Chinese medicine micro powder and egg yolk refined oil according to a weight ratio of 1: 1; the traditional Chinese medicine micro powder comprises: rhubarb charcoal powder 20 g, oil-prepared sanguisorba root charcoal powder 30 g, gromwell powder 20 g, dried alum powder 10 g and borneol powder 5 g.

The manufacturing method comprises the following steps:

a. firstly, egg oil preparation: boiling fresh egg with water until yolk is cooked thoroughly, cooling cooked egg, removing skin and egg white to obtain yolk; crushing yolk, putting into a stainless steel pot, stir-frying the yolk with slow fire, and taking yolk oil along with the frying after the yolk turns black and produces oil; preserving the obtained egg yolk oil, and naturally cooling the rest.

b. Preparing garden burnet charcoal by using oil: adding the garden burnet blocks and part of the egg yolk oil stored in the stainless steel pot, stir-frying the garden burnet blocks at 280 ℃ for 2-3 minutes at 270-.

c. 20 g of rhubarb charcoal, 30 g of oil-prepared garden burnet root charcoal, 20 g of lithospermum, 10 g of dried alum and 5 g of borneol are taken, mixed and ground into fine powder, the traditional Chinese medicine fine powder and the egg oil are taken according to the weight ratio of 1:1, mixed and stirred evenly, and then are stored in a glass bottle in a sealed manner at low temperature.

The eczema medicine application is made by taking non-woven fabrics as an application surface layer 3, and pressing a circular tooth hole ring at a certain distance on the non-woven fabrics for making a through hole 4. Selecting medicinal sponge as the medicine applying layer 2, covering the non-woven fabric on the medicine applying layer 2, selecting four points on the periphery of the through hole 4, and sewing the applying surface layer 3 and the medicine applying layer 2 together by using threads. The prepared traditional Chinese medicine egg yolk oil cream is uniformly coated on the other surface of the medicine coating layer 2, a medicine coating surface is formed on the surface of the medicine coating layer 2, and a plastic film is attached to the medicine coating surface to be used as a protective layer 1. After the three layers are compounded, the whole is rolled and stored at low temperature. When in use, the patch is cut according to the required length, the protective layer 1 is removed, and the patch face is opposite to the eczema part of the patient and fixed on the skin of the patient. The hole cover 41 is opened, so that ventilation can be facilitated or yolk oil can be added for the second time, the temperature rise of the surface of the skin below the medicine patch can be prevented, eczema treatment is facilitated, the yolk oil can be supplemented, and the regeneration and metabolism of the skin are promoted.

When the garden burnet is processed, high-temperature egg yolk oil is sprayed on the garden burnet which is fried to be yellow, the garden burnet is heated uniformly, the temperature inside and outside is raised rapidly, the effective components such as tannin, soluble calcium and the like are protected by the egg yolk oil, and the loss of the effective components caused by local overheating of the garden burnet blocks is avoided.

Example of clinical application: the eczema patch is applied to 20 patients with allergy caused by bandage ligature of interventional therapy, and after the eczema patch is used for 3 days, the eczema skin of 18 patients is scabbed, and the other 2 patients are obviously improved.

Claims

1. An eczema drug application is characterized by comprising a protective layer (1), a drug application layer (2) and a face application layer (3) which are connected in a layered manner, wherein the drug application layer (2) is in a mesh shape, one face of the drug application layer (2) is a drug application face (21), and a drug application composition is adsorbed on the drug application face; the protective layer (1) and the application surface layer (3) are respectively arranged on two surfaces of the medicine coating layer (2), wherein the protective layer (1) is attached to the outside of the medicine coating surface (21), the protective layer (1) is movably connected with the medicine coating surface (21), and the protective layer (1) can be conveniently separated from the medicine coating layer (2); the dressing layer (3) is covered on the other side of the medicine coating layer (2), a connecting node (5) for preventing the dressing layer (3) from separating from the medicine coating layer (2) is arranged between the dressing layer (3) and the medicine coating layer, and a through hole (4) is arranged on the dressing layer (3).

2. The eczema plaster according to claim 1, wherein the drug coating layer (2) is a sponge body, the through hole (4) is provided with a hole cover (41) integrally connected with the dressing layer (3), the dressing layer (3) around the hole cover (41) is provided with a connecting node (5), and the connecting node (5) is a binding wire for connecting the dressing layer (3) and the drug coating layer (2).

3. The eczema medical application according to claim 1, wherein the protective layer (1), the medical application layer (2) and the application surface layer (3) are all in the shape of strips, the eczema medical application is formed by compounding and overlapping three layers of strips, a plurality of through holes (4) are formed in the application surface layer (3) along the length direction of the application surface layer, and the medical application is rolled for storage so as to be cut for use as required.